Pancreatic neuroendocrine tumors (pNETs) represent about 7% of all NETs, 8.7% of
gastroenteropancreatic NETs (GEP-NETs) and 1–2% of all pancreatic neoplasms. In the last …

Abstract Background: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors
with various clinical manifestations and biological behavior. Among the most common …

Introduction: Neuroendocrine tumors of the pancreas (pNETs) represent only 1% to 2% of all
pancreatic neoplasms. These tumors can be classified as functional or nonfunctional tumors; …

The vast majority of new pNET diagnoses consist of incidentally discovered lesions on cross-
sectional imaging. The biologic behavior of pNETs is defined by the grade and stage of the …

In this article, we aimed to review the literature on the clinics and management of
nonfunctional pancreatic neuroendocrine tumors (NPNET). Pancreatic neuroendocrine …

Pancreatic neuroendocrine tumors (NETs) are uncommon disease, about which little is
known. Pancreatic NETs are usually slow growing and their malignant potential are often …

The incidence of pancreatic neuroendocrine tumors (PNETs) has significantly increased in
recent years, although this may reflect better detection and improved diagnosis, in addition …

Pancreatic neuroendocrine tumours (pNETs) are rare and heterogeneous group of
neoplasms presenting with a wide variety of symptoms and biological behaviour, from …

Pancreatic neuroendocrine tumors (PanNETs) manifest with a range of symptoms and pose
a therapeutic challenge. A team approach, in which many specialists come together, is …

Pancreatic neuroendocrine tumors (pNETs) are rare heterogeneous tumors that have been
steadily increasing in both incidence and prevalence during the past few decades …